FDA Adverse Event Malfunction Summary report: N

I-STAT ACT KAOLIN CARTRIDGE

MDR report key: 25226215 · Received May 20, 2026

Report

Report Number
2245578-2026-00111
Event Type
Malfunction
Date Received
May 20, 2026
Date of Event
May 6, 2026
Report Date
May 20, 2026
Manufacturer
ABBOTT POINT OF CARE INC.
Product Code
JBP
UDI-DI
10054749000156
PMA / PMN Number
K023582
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WI, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

APOC INCIDENT # (B)(4). APOC LABELING WILL BE EVALUATED DURING THE INVESTIGATION AS PERTAINING TO THE EVENT.

Description of Event or Problem · 0

ON 07-MAY-2026, ABBOTT POINT OF CARE WAS CONTACTED BY A CUSTOMER REGARDING I-STAT ACT KAOLIN CARTRIDGES THAT YIELDED A DISCREPANT RESULTS ON A 65 YEAR OLD FEMALE PATIENT WITH AFIB. THERE WAS NO ADDITIONAL PATIENT INFORMATION AVAILABLE. RETURN PRODUCT IS AVAILABLE FOR INVESTIGATION. DATE: TESTED: RESULTS: HEPARIN: TIME: 7500UNITS 10:40 (B)(6) 2026 100:56:12 245SEC; 4000UNITS 10:58 (B)(6) 2026 11:16:54 286SEC; 4000UNITS 11:26 (B)(6) 2026 11:30:21 >1000SEC; (B)(6) 2026 11:31:18 307SEC; (B)(6) 2026 11:54:07 394SEC; (B)(6) 2026 12:43:13 342SEC; 4000UNITS 12:48 (B)(6) 2026 13:23:36 353SEC; 2000UNITS 13:25; AT THIS TIME THERE IS NO REASON TO SUSPECT A MALFUNCTION EXISTS. THE REPORTING DECISION WAS BASED ON THE LIMITED INFORMATION AVAILABLE THAT SUGGESTS THE PRODUCT WAS NOT PERFORMING WITHIN THE VARIABILITY OF THE ASSAY. AN INVESTIGATION IS UNDERWAY. PER I-STAT SYSTEM MANUAL (ART: 714185-00Q), THE I-STAT KAOLIN ACTIVATED CLOTTING TIME (KAOLIN ACT) TEST IS AN IN VITRO DIAGNOSTIC TEST THAT USES FRESH, WHOLE BLOOD. AND IS USED TO MONITOR HIGH-DOSE HEPARIN ANTICOAGULATION FREQUENTLY ASSOCIATED WITH CARDIOVASCULAR SURGERY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
197830 I-STAT ACT KAOLIN CARTRIDGE ACT KAOLIN CARTRIDGE JBP ABBOTT POINT OF CARE INC. NA R26100A 10054749000156

Patients

Seq Age Sex Outcome Treatment
1